Literature DB >> 10956567

Enlarged cavum septi pellucidi in patients with schizophrenia: clinical and cognitive correlates.

P Nopoulos1, A Krie, N C Andreasen.   

Abstract

Enlarged cavum septi pellucidi (CSP) is a neurodevelopmental anomaly that has been associated with schizophrenia. This study was designed to evaluate, in patients with schizophrenia, the relationship between the severity of this anomaly and measures of symptom and cognitive skills. Three groups were used: patients with large CSP (n=14), patients without large CSP (n=14), and healthy control subjects (n=14). In patients with large CSP, a significant, inverse relationship was found between size of CSP and measures of cognitive deficit. Thus, the greater the size of the anomaly, the greater the cognitive deficit. No relationship was found between severity of CSP and symptom measures.

Entities:  

Mesh:

Year:  2000        PMID: 10956567     DOI: 10.1176/jnp.12.3.344

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  18 in total

1.  The relationship between large cavum septum pellucidum and antisocial behavior, callous-unemotional traits and psychopathy in adolescents.

Authors:  Stuart F White; Sarah Brislin; Stephen Sinclair; Katherine A Fowler; Kayla Pope; R James R Blair
Journal:  J Child Psychol Psychiatry       Date:  2012-08-31       Impact factor: 8.982

2.  MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Mina L Xu; Larry J Seidman; Martina M Voglmaier; Margaret A Niznikiewicz; Erin Connor; Martha E Shenton
Journal:  Schizophr Res       Date:  2006-10-05       Impact factor: 4.939

3.  Volumetric analysis of septal region in schizophrenia and affective disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Dieter Krell; Renate Stauch; Kurt Trübner; Henrik Dobrowolny; Siegfried Kropf; Hendrik Bielau; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-16       Impact factor: 5.270

4.  Platelet-derived growth factor C deficiency in C57BL/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities.

Authors:  Linda Fredriksson; Ingrid Nilsson; Enming J Su; Johanna Andrae; Hao Ding; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence
Journal:  Am J Pathol       Date:  2012-01-09       Impact factor: 4.307

5.  The relationship between cavum septum pellucidum and psychopathic traits in a large forensic sample.

Authors:  Dana Crooks; Nathaniel E Anderson; Matthew Widdows; Nia Petseva; Michael Koenigs; Charles Pluto; Kent A Kiehl
Journal:  Neuropsychologia       Date:  2018-03-12       Impact factor: 3.139

6.  Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study.

Authors:  Kiyoto Kasai; Robert W McCarley; Dean F Salisbury; Toshiaki Onitsuka; Susan Demeo; Deborah Yurgelun-Todd; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  Schizophr Res       Date:  2004-11-01       Impact factor: 4.939

7.  MRI study of the cavum septum pellucidum in obsessive-compulsive disorder.

Authors:  Myong-Wuk Chon; Jung-Seok Choi; Do-Hyung Kang; Myung Hun Jung; Jun Soo Kwon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-25       Impact factor: 5.270

Review 8.  The neurobiology of psychopathic traits in youths.

Authors:  R James R Blair
Journal:  Nat Rev Neurosci       Date:  2013-10-09       Impact factor: 34.870

9.  Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome.

Authors:  Elliott A Beaton; Yufeng Qin; Vy Nguyen; Joel Johnson; Joseph D Pinter; Tony J Simon
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

10.  The septum pellucidum and its variants. An MRI study.

Authors:  Christine M Born; Eva M Meisenzahl; Thomas Frodl; Thomas Pfluger; Maximilian Reiser; H J Möller; Gerda L Leinsinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.